💊 Letrozole (Letrozole)
Letrozole is an oral tablet belonging to the aromatase inhibitor class. It is used to treat breast cancer in postmenopausal women. It is prescribed by a doctor, who determines the dose and duration of treatment.
In Arabic: ليتروزول🏷️ Brand names & manufacturers
Packages shown are US-market (DailyMed). Brands available in Palestine are in the price section below.✅ What it is used for
- Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer
- Extended adjuvant treatment of early breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen
- First-line treatment of postmenopausal women with hormone receptor positive or unknown, locally advanced or metastatic breast cancer
- Treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy
🧪 Active ingredient
The active ingredient is letrozole, a nonsteroidal aromatase inhibitor. It blocks the enzyme that converts androgens into estrogens, lowering estrogen levels, the hormone that stimulates the growth of some breast cancers.
🌿 Benefits
- Lowers estrogen levels that stimulate the growth of some breast cancers
- Helps treat early and advanced breast cancer in postmenopausal women
- Can be taken without regard to meals
📝 How to use
- Taken by mouth once daily, with or without meals
- The dose and duration are set by your doctor or pharmacist and should not be changed without consulting them
- In patients with cirrhosis and severe hepatic dysfunction, the doctor may prescribe a reduced dose (one tablet every other day)
- No dose adjustment is needed in renal impairment if creatinine clearance is 10 mL/min or higher
💊 Dosage forms
- 2.5 mg film-coated tablets: dark-yellow, round, convex, unscored, debossed 'TEVA' on one side and 'B1' on the other
⚠️ Common side effects
- Hot flashes
- Joint pain (arthralgia)
- Flushing
- Weakness (asthenia)
- Edema (swelling)
- Headache
- Dizziness
- High cholesterol
- Increased sweating
- Bone pain and musculoskeletal pain
- Nausea
- Fatigue
🚨 Serious — seek medical help
- Decreased bone mineral density with increased risk of fractures and osteoporosis
- Increased total cholesterol
- Allergic-type reactions (particularly in people sensitive to tartrazine)
⛔ Do not use if
- Pregnancy
- Known hypersensitivity to the active substance or any of the excipients
❗ Warnings & precautions
- Contains FD&C Yellow No. 5 (tartrazine), which may cause allergic-type reactions (including bronchial asthma) in susceptible persons, especially those with aspirin hypersensitivity
- Bone mineral density may decrease; monitoring should be considered
- Total cholesterol may increase; monitoring should be considered
- Fatigue, dizziness and somnolence may occur; use caution when operating machinery
- Can cause fetal harm; a pregnancy test is advised for females of reproductive potential, along with effective contraception
- Discuss with your doctor before use in cirrhosis or severe hepatic impairment
🔄 Drug interactions
- Tamoxifen: co-administration reduced letrozole plasma levels by 38% on average
- Cimetidine: no clinically significant effect on letrozole pharmacokinetics
- Warfarin: no clinically significant effect of letrozole on warfarin pharmacokinetics
- There is no clinical experience to date with letrozole combined with other anticancer agents
🤰 Pregnancy
Contraindicated in pregnancy because it can cause fetal harm. Postmarketing reports describe spontaneous abortions and congenital birth defects, and animal studies showed fetal loss and malformations of the renal and skeletal systems. A pregnancy test and effective contraception are advised for females of reproductive potential.
🍼 Breastfeeding
Breastfeeding is not advised during treatment.
🧒 Children
Safety and effectiveness in pediatric patients have not been established. Studies in young rats showed adverse effects on bone growth and reproductive development.
👴 Older adults
No overall differences in safety or efficacy were observed between older and younger patients in studies, though greater sensitivity in some older individuals cannot be ruled out; more adverse reactions were generally reported in elderly patients.
🌡️ Storage
Store at 20° to 25°C (68° to 77°F) in a tight, light-resistant container with a child-resistant closure. Keep out of the reach of children.
⏰ Missed dose
The label does not address missed doses. Ask your doctor or pharmacist, and do not double a dose on your own.
🆘 Overdose
Isolated cases have been reported (highest single dose 62.5 mg, or 25 tablets) with no serious adverse reactions. If an overdose occurs, seek medical help immediately; vomiting could be induced if the patient is alert, with supportive care and frequent monitoring of vital signs.
💰 Price & brands in your area
🏛️ Official price in Palestine — Ministry of Health price list:
| Product | Company | Pack | Price |
|---|---|---|---|
| LETROZOLE TAB 2.5MG LETROZOLE | Teva | 30 tab | 59 ₪ |
📍 Find the nearest pharmacy
Your location is used only in your browser to show nearby pharmacies — we don't store it.
Open in Google Maps👨⚕️ For healthcare professionals
Mechanism of action
Letrozole is a nonsteroidal competitive inhibitor of aromatase; it binds the heme of the cytochrome P450 subunit, reducing estrogen biosynthesis in all tissues. At 0.1 to 5 mg daily it suppresses plasma estradiol, estrone and estrone sulfate by 75% to 95% from baseline, without significantly affecting adrenal corticosteroid, aldosterone or thyroid hormone synthesis.
Labeled dosing
General adult dosing per the label: 2.5 mg orally once daily without regard to meals. In cirrhosis with severe hepatic dysfunction: 2.5 mg every other day. No adjustment in renal impairment if creatinine clearance is ≥ 10 mL/min. Dose and duration are determined by the treating physician.
- In the adjuvant and extended adjuvant settings the optimal duration is unknown (median treatment 5 years in studies); discontinue at relapse
- In advanced disease, continue until tumor progression is evident
- Consider monitoring BMD (median lumbar spine decrease of 4.1% at 24 months vs. +0.3% with tamoxifen) and cholesterol
- In BIG 1-98, bone fracture incidence was 14.7% with letrozole vs. 11.4% with tamoxifen
🎓 Key points for students
- Class: nonsteroidal aromatase inhibitor
- Mechanism: competitive aromatase inhibition lowering estrogen synthesis
- Indication: breast cancer in postmenopausal women (adjuvant, extended adjuvant, advanced)
- Dose: 2.5 mg once daily; every other day in severe hepatic dysfunction with cirrhosis
- Contraindications: pregnancy and hypersensitivity
- Key adverse effects: hot flashes, arthralgia, bone density loss, hypercholesterolemia
- Interaction: tamoxifen lowers letrozole levels by about 38%
EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.
Try EME free How we protect your data❓ FAQ
What is letrozole used for?
It is used to treat breast cancer in postmenopausal women, in both early (adjuvant) and advanced disease.
How is letrozole taken?
One tablet by mouth once daily, with or without food, as prescribed by your doctor.
Can it be used during pregnancy or breastfeeding?
No. It is contraindicated in pregnancy because it can harm the fetus, and breastfeeding is not advised during treatment.
What are the most common side effects?
Hot flashes, joint pain, fatigue, headache, dizziness, high cholesterol and bone pain.
Does it affect the bones?
Yes. It may decrease bone mineral density and increase the risk of osteoporosis and fractures, so your doctor may monitor it.
⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2025-11), simplified. Updated: 2026-11-15.
Femara🏭 Novartis Pharmaceuticals Corporation
Letrozole🏭 AvKARE
Letrozole🏭 Breckenridge Pharmaceutical, Inc.